Everything below concerns somatotroph. We keep the language plain, cite what the science says, and separate well-supported claims from open questions.
Last reviewed on 2025-11-16. Where a claim depends on a specific study, the study is described rather than over-claimed.
Tesamorelin binds to growth hormone-releasing hormone receptors on the surface of pituitary somatotroph cells. This binding activates adenylate cyclase, raising intracellular cyclic AMP levels and triggering the release of growth hormone into circulation. The elevated growth hormone then stimulates hepatic production of insulin-like growth factor 1. Because the effect is mediated through the endogenous axis, secretion remains subject to feedback regulation. This distinguishes it from direct growth hormone administration, which bypasses pituitary control entirely.
Clinical investigation has focused on HIV-associated lipodystrophy, a condition in which antiretroviral therapy contributes to abnormal fat distribution. Excess visceral adipose tissue accumulates in the abdomen while peripheral fat may be lost. Tesamorelin was evaluated for reducing this visceral fat depot, with trials measuring changes in abdominal fat by imaging rather than by body weight alone. The rationale rests on the known lipolytic effects of growth hormone. Effects on visceral fat are documented, while long-term outcomes regarding cardiovascular risk remain less clearly established.
Tesamorelin is a synthetic peptide analog of growth hormone-releasing hormone, composed of 44 amino acids. It was designed to retain the biological activity of the native hormone while resisting rapid enzymatic degradation. The compound is classified as a growth hormone secretagogue and belongs to the broader family of hypothalamic releasing factors. In research and clinical settings, it is studied for its ability to stimulate pituitary growth hormone release. Its structure includes a modification at the N-terminus that contributes to an extended half-life relative to native growth hormone-releasing hormone.
Tesamorelin is a synthetic peptide that acts as an analog of growth hormone-releasing hormone, a natural hypothalamic signal. Its sequence corresponds to the forty-four amino acid form of the human hormone, with a small acyl group attached near the amino terminus. That modification slows enzymatic breakdown and extends the time the peptide remains active in circulation. The compound was developed as a pharmacological way to raise endogenous growth hormone output rather than supplying the hormone directly.
After injection, the peptide binds receptors on somatotroph cells in the anterior pituitary. Receptor activation raises intracellular cyclic AMP and triggers release of stored growth hormone into the bloodstream. Because the compound works through the body's own regulatory system, growth hormone pulses retain much of their normal feedback control. Repeated administration also raises insulin-like growth factor 1, a hormone produced mainly in the liver. Investigators treat that rise as a marker that the pituitary axis has been engaged.
Clinical study of tesamorelin has centered on adults with HIV-associated lipodystrophy, a condition in which abdominal fat accumulates while peripheral fat is lost. In controlled trials, treated participants showed reductions in visceral adipose tissue measured by imaging, alongside modest shifts in some lipid values. Effects on subcutaneous fat were smaller and less consistent across studies. Whether these changes translate into fewer cardiovascular events remains an open question, because the trials were not designed or powered to answer it.
| Property | Value | Notes |
|---|---|---|
| Molecular class | Synthetic peptide | Analog of growth hormone-releasing hormone |
| Amino acid length | 44 residues | Matches the native peptide backbone |
| Molecular weight | Approximately 5135 Da | Calculated from the peptide sequence |
| Receptor target | GHRH receptor | Expressed on pituitary somatotroph cells |
| Primary studied use | Visceral fat reduction | Investigated in HIV-associated lipodystrophy |
Tesamorelin is a synthetic peptide of forty-four amino acids whose sequence reproduces human growth hormone-releasing hormone. Its distinguishing feature sits at the amino terminus, where a trans-3-hexenoyl group replaces the free amine. That acylation slows cleavage by dipeptidyl peptidase IV, an enzyme that otherwise removes the first two residues and inactivates the natural hormone quickly. The modified peptide therefore persists longer in circulation while keeping the same receptor target. It is handled as a lyophilized solid and dissolved shortly before use.
Signaling begins at the GHRH receptor, a class B G protein-coupled receptor displayed on somatotroph cells of the anterior pituitary. Receptor occupancy activates Gs proteins, which raise adenylyl cyclase activity and intracellular cyclic AMP, in turn driving protein kinase A dependent pathways. The downstream output is synthesis and pulsatile secretion of growth hormone into the bloodstream. Hepatic tissue and peripheral sites respond by increasing insulin-like growth factor 1 production. Somatostatin and IGF-1 itself supply negative feedback that caps the size and duration of each secretory burst.
Metabolic interest in this compound centers on fat distribution rather than on hormone levels alone. Imaging trials in adults with excess abdominal fat report reductions in visceral adipose tissue, while subcutaneous depots change comparatively little. Growth hormone and IGF-1 are presumed to carry the effect, but the separate contribution of each is not firmly established. Whether these changes persist after treatment stops, and whether they alter longer-term health outcomes, remain open questions that published work does not answer consistently.
Tesamorelin is a synthetic peptide analog of growth hormone-releasing hormone, built from 44 amino acids. Its sequence follows the natural human GHRH(1-44) backbone, with a trans-3-hexenoyl group attached to the N-terminal tyrosine. This modification blocks recognition by dipeptidyl peptidase IV, the enzyme that rapidly truncates the native hormone in circulation. The result is a molecule with a substantially longer plasma residence time than unmodified GHRH, which makes it practical for clinical and laboratory study.
Receptor-level activity begins when the peptide binds the GHRH receptor, a class B G-protein-coupled receptor found on pituitary somatotroph cells. Occupancy triggers Gs-mediated activation of adenylyl cyclase and a rise in intracellular cyclic AMP, which in turn promotes synthesis and pulsatile release of growth hormone. Because the compound acts upstream of the growth hormone axis rather than supplying hormone directly, its effect depends on intact pituitary function. Binding studies in cell culture and animal models have established this pathway; the detailed kinetics of receptor recycling in humans remain less well characterized.
The hexenoyl cap slows the enzyme step that trims the amino terminus of native GHRH, the same step that shortens its active lifetime in circulation. As a result, the modified peptide persists longer in plasma than the unmodified hormone in side-by-side comparison. Receptor activity stays broadly comparable, because the added group sits away from the residues that contact the binding site. This combination, preserved receptor activity with reduced degradation, explains why the analog was developed instead of the native sequence.
Several compounds share the GHRH framework, including sermorelin, the shorter 1-29 fragment, and other analogs built on the full 1-44 chain. Naming follows a common convention: a stem that identifies the peptide plus a suffix marking analog status. Reports may describe tesamorelin by its sequence fragment, as a GHRH(1-44) analog, or by its amino-terminal modification. Indexing the compound therefore requires searching all of these forms, since some older literature predates the current international nonproprietary name.
== Further reading == Juego, Bonn (2017). "The Philippines 2017: Duterte-led authoritarian populism and its liberal-democratic roots" (PDF). Asia Maior; the Journal of the Italian Think Tank on Asia Founded by Giorgio Borsa in 1989. XXVIII. Viella s.r.l. & Associazione Asia Maior: 129–163. ISSN 2385-2526. Archived from the original (PDF) on December 1, 2022. Retrieved December 1, 2022. "The Punisher". Eye for an Eye. (Vice) Bethesda Softworks LLC. Archived from the original on March 10, 2016. Retrieved September 14, 2016.
== The Real Housewives of Cheshire == In January 2015, the British reality TV series The Real Housewives of Cheshire debuted with Pickston, Leanne Brown, Magali Gorré, Tanya Bardsley, Lauren Simon and Dawn Ward. A British adaptation of the long-running American franchise The Real Housewives, the series follows the lives of a group of wealthy women in Cheshire. Pickston left the show at the end of fifth series, in 2017, after appearing in 55 episodes and three reunions. Pickston returned to the show in a guest capacity in the sixteenth series (2023) and featured in a recurring capacity for the seventeenth series (2024). The eighteenth series (2025) celebrated ten years of the show, which Pickston appeared in. Pickston returned to the show in a full-time role from the nineteenth series, in 2026. Pickston won the Best Female Personality Award at the Sixth Annual National Reality TV Awards.
== Practical uses == While at first the chemical garden may appear to be primarily a toy, some serious work has been done on the subject. For instance, this chemistry is related to the setting of Portland cement, the formation of hydrothermal vents, and the corrosion of steel surfaces on which insoluble tubes can be formed. The nature of the growth of the insoluble silicate tubes formed within chemical gardens is also useful in understanding classes of related behavior seen in fluids separated by membranes. In various ways, the growth of the silicate tubes resembles the growth of spikes or blobs of ice extruded above the freezing surface of still water, the patterns formed by drying gum as it drips from wounds in trees such as Eucalyptus, and the way molten wax forms twig-like growths, either dripping from a candle, or floating up through cool water. The fundamental principles governing their self-assembly and membrane dynamics have been extensively leveraged across multiple scientific disciplines, including biomedicine (e.g., engineering cellular scaffolds and bone substitute materials), and astrobiology (e.g., modeling prebiotic compartmentalization and the emergence of life in hydrothermal vent environments). Chemobrionic materials have also been investigated as active layers in memristive devices for neuromorphic computing.
Sources: en.wikipedia.org
In the context of chemistry, energy is an attribute of a substance as a consequence of its atomic, molecular or aggregate structure. Since a chemical transformation is accompanied by a change in one or more of these kinds of structures, it is invariably accompanied by an increase or decrease of energy of the substances involved. Some energy is transferred between the surroundings and the reactants of the reaction in the form of heat or light; thus the products of a reaction may have more or less energy than the reactants. A reaction is said to be exergonic if the final state is lower on the energy scale than the initial state; in the case of endergonic reactions the situation is the reverse. A reaction is said to be exothermic if the reaction releases heat to the surroundings; in the case of endothermic reactions, the reaction absorbs heat from the surroundings. Chemical reactions are invariably not possible unless the reactants surmount an energy barrier known as the activation energy. The speed of a chemical reaction (at given temperature T) is related to the activation energy E, by the Boltzmann's population factor
=== Zhejiang === In October 2002, Xi left Fujian and became the deputy governor, acting governor and deputy Party secretary of neighbouring Zhejiang. He eventually took over as provincial Party Committee secretary after the 16th Party National Congress, occupying a top provincial office for the first time in his career. In November 2002, he was elected a full member of the 16th Central Committee by the 16th Party National Congress, marking his ascension to the national stage. While in Zhejiang, Xi presided over reported growth rates averaging 14% per year. During this period, Zhejiang increasingly transitioned away from heavy industry. Xi's career in Zhejiang was marked by a tough and straightforward stance against corrupt officials. This earned him a name in the national media and drew the attention of China's top leaders. Between 2004 and 2007, Li Qiang acted as Xi's chief of staff through his position as secretary-general of the Zhejiang Party Committee, where they developed close mutual ties. During this period, Xi and Li drafted the Double Eight Strategy, which listed eight comparative advantages of Zhejiang and eight corresponding actions to improve the province.
== Generation == Phosphine oxide has been claimed as the product of a reaction of phosphine with vanadium oxytrichloride as well as with chromyl chloride. The product was obtained by matrix isolation. It has also been reported relatively stable in a water-ethanol solution by electrochemical oxidation of white phosphorus, where it slowly disproportionates into phosphine and hypophosphorous acid. Phosphine oxide is reported as an intermediate in the room-temperature polymerization of phosphine and nitric oxide to solid PxHy.
Sources: en.wikipedia.org
When cold air damming occurs, it allows for cold air to surge toward the equator in the affected area. In calm, non-stormy situations, the cold air will advance unhindered until the high-pressure area can no longer exert any influence because of a lack of size or its leaving the area. The effects of cold air damming become more prominent (and also more complicated) when a storm system interacts with the spreading cold air. The effects of cold air damming east of the Cascades in Washington are strengthened by the bowl or basin-like topography of Eastern Washington. Cold Arctic air flowing south from British Columbia through the Okanogan River valley fills the basin, blocked to the south by the Blue Mountains. Cold air damming causes the cold air to bank up along the eastern Cascade slopes, especially into the lower passes, such as Snoqualmie Pass and Stevens Pass. Milder, Pacific-influenced air moving east over the Cascades is often forced aloft by the cold air in the passes, held in place by cold air damming east of the Cascades. As a result, the passes often receive more snow than higher areas in the Cascades, which supports skiing at Snoqualmie and Stevens passes.
While in graduate school in the 1960s she began working on corticotropin, and while trying to purify this hormone later in her career she made a chance finding of a peptide called substance P. This event subsequently led to her life's work of researching substance P and another peptide she chemically isolated and defined, neurotensin.
== Non-medical hormonal interventions == In addition to the use of medication to produce tumor-suppressing endocrine alterations, destruction of endocrine organs through surgery or radiation therapy are also possible. Surgical castration, or removal of the testes in males and ovaries in females, have been widely used in the past to treat hormone-responsive prostate cancer and breast cancer respectively. However, these invasive methods have been widely supplanted by the use of GnRH agonists, and other forms of pharmacologic castration. There are still situations in which surgical castration may be beneficial such as in special cases for women with high risk BRCA mutations.
Sources: en.wikipedia.org
It is a synthetic analog of growth hormone-releasing hormone, a hypothalamic peptide. It functions as a growth hormone secretagogue acting at pituitary receptors. The classification separates it from direct growth hormone products.
The synthetic peptide incorporates modifications that slow enzymatic breakdown in circulation. Native growth hormone-releasing hormone is short-lived, whereas the analog is designed for greater stability. The core amino acid backbone is largely retained.
The main studied application is reduction of excess visceral abdominal fat in HIV-associated lipodystrophy. Research has measured fat changes through imaging. Findings concern fat distribution rather than overall body weight.
It is a laboratory-made peptide that mimics growth hormone-releasing hormone. It prompts the pituitary gland to release growth hormone and has been studied mainly in adults with HIV-associated lipodystrophy.